Association of Sleep Duration with Cardio-metabolic Risk Leading to Development of Atherosclerotic Cardiovascular Disease
Not Applicable
- Conditions
- Atherosclerotic cardiovascular disease
- Registration Number
- JPRN-UMIN000037643
- Lead Sponsor
- Department of Health Planning Center, Nihon University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria included refusal to provide consent for participation in the study, current treatment of insulin therapy, positive history of atherosclerotic cardiovascular disease (ASCVD), absence of measurement of the serum lipid, fasting blood glucose, immunoreactive insulin, hemoglobin A1c (HbA1c), waist circumference (WC) and absence of a record of the average sleep duration per week.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method